MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen Retained Earnings 2011-2026 | INGN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -176 M | -153 M | -117 M | -14.5 M | 69.3 M | 75.6 M | 81.4 M | 60.5 M | 8.64 M | -12.4 M | -45.1 M | -56.7 M | -62.6 M | -81 M | -75.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.4 M | -176 M | -33.2 M |
Quarterly Retained Earnings Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -168 M | -163 M | -159 M | -153 M | -143 M | -137 M | -132 M | -117 M | -90.4 M | -44.7 M | -34.8 M | -14.5 M | 42.1 M | - | 55.1 M | 69.3 M | 92.1 M | 80 M | 74.9 M | 75.6 M | 75.6 M | 75.6 M | 75.6 M | 81.4 M | 81.4 M | 81.4 M | 81.4 M | 60.5 M | 60.5 M | 60.5 M | 60.5 M | 8.64 M | 8.64 M | 8.64 M | 8.64 M | -12.4 M | -12.4 M | -12.4 M | -12.4 M | -45.1 M | -45.1 M | -45.1 M | -45.1 M | -56.7 M | -56.7 M | -56.7 M | -56.7 M | -62.6 M | -62.6 M | -62.6 M | -62.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.1 M | -168 M | -14.9 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.48 B | $ 191.66 | 0.84 % | $ 14.4 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.67 | 0.08 % | $ 1.71 B | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.42 | -2.01 % | $ 128 M |  France |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 60.99 | -5.03 % | $ 90.3 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.65 | -2.26 % | $ 40.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.16 | -5.34 % | $ 316 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 25.4 | -2.53 % | $ 215 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.05 | -0.94 % | $ 17.8 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 96.82 | 1.65 % | $ 13.1 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 5.49 | 0.73 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.12 | - | $ 1.29 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.88 | 0.18 % | $ 390 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 65.81 | -1.95 % | $ 3.59 B |  Britain |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 56.97 | -1.08 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 39.68 | 1.54 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 89.32 | -0.98 % | $ 3.1 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.65 | -0.6 % | $ 391 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.8 | - | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.44 | 0.56 % | $ 47.6 B | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.55 | -6.41 % | $ 66.4 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.9 | 4.73 % | $ 37.7 M | USA |
 |
Smith & Nephew plc
SNN
|
4.96 B | $ 34.21 | -0.44 % | $ 23.8 B | Britain |